Skip to main content
. Author manuscript; available in PMC: 2012 Jun 20.
Published in final edited form as: J Neurooncol. 2011 Nov 27;107(2):269–280. doi: 10.1007/s11060-011-0756-5

Fig. 2.

Fig. 2

CHLA-200, CHLA-259 and CHLA-266 show higher resistance to most chemotherapy drugs tested as compared to DAOY cells. Cytotoxicity was analyzed after 4 days exposure using the DIM-SCAN assay to cisplatin (CDDP), cyclophosphamide (as 4-hydroperoxycyclophosphamide, 4-HC), etoposide (ETOP), melphalan (L-PAM), topotecan (TPT), vincristin (VINC), and ferentinide (4-HPR). For each drug concentration n = 12